In the present study, we focused on the comprehensive assessment of dynamic modular variations, re-wiring, among gene interactions resulting from cancer progression in estrogen-receptor-positive (ER+) breast cancer patients (315 patients included). This evidence concerns the gene ESR1 and cancer.